Ysios Capital Partners
LightNews LightNews
banner
ysioscapital.bsky.social
Ysios Capital Partners
@ysioscapital.bsky.social
66 followers 83 following 57 posts
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Sign up & stay tuned http://eepurl.com/duXVDv 📩
Posts Replies Media Videos
Pinned
ysioscapital.bsky.social
Ysios Capital Partners @ysioscapital.bsky.social · Sep 16
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊

🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need

👉 buff.ly/aO4iHwV

#YsiosPortfolio #vc
VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment
ysioscapital.bsky.social
#PortfolioNews | Memo Therapeutics partners with CSL to advance recombinant polyclonal IgG, validating its DROPZYLLA® platform. 🚀🧬

👉 buff.ly/uCOUhUh

#YsiosPortfolio
February 9, 2026 at 3:19 PM
Reposted by Ysios Capital Partners
thenewbcnpost.bsky.social
👉 Telescope Biotech Fund tanca el 2025 amb un retorn net del 52,5% des del seu llançament al febrer, i s'erigeix com el fons d'inversió lliure més rendible de l'any a nivell estatal

✍️ Anna Badia

www.thenewbarcelonapost.cat/fons-cotitza...
El fons de cotitzades 'biotech' d’Ysios i Andbank prem l'accelerador
Telescope Biotech Fund tanca el 2025 amb un retorn net del 52,5% des del seu llançament al febrer, i s'erigeix com el fons d'inversió lliure més rendible de l'any a nivell estatal
www.thenewbarcelonapost.cat
January 21, 2026 at 10:25 AM
ysioscapital.bsky.social
🔬#Portfolionews | Inbiomotion’s MAF Test® included in 2025 SEOM-GEICAM-SOLTI guidelines for early #breast #cancer.

🎯 Advancing MAF-based clinical decision-making!
👉 buff.ly/zSld1qQ

#oncology #brestcancer
January 16, 2026 at 11:34 AM
Reposted by Ysios Capital Partners
biocat.cat
💡 Jordi Vidal (Kibo Ventures), Miriam Damas (Ship2B), Josep Miquel Torregrosa (Suma Capital) and Íñigo López-Huerta (@ysioscapital.bsky.social) share insights on purpose-driven venture capital.

Don’t miss this session to discover how leading VCs invest with impact.
December 10, 2025 at 10:35 AM
ysioscapital.bsky.social
📢 #YsiosTeam | We are delighted to announce the promotion of Almudena Méndez and Sriram Balusu to #Associate at
@ysioscapital.bsky.social ! 🎉

👏 Congratulations, very well deserved!
🙋‍♀️ Meet Almudena lnkd.in/dSrMw4Ya
🙋 Meet Sriram: bit.ly/SriramB

#vc #talent
November 7, 2025 at 11:13 AM
ysioscapital.bsky.social
#Telescope I 🔭 The Q3 report for #TelescopeBiotech, a public equities fund advised by @ysioscapital.bsky.social , is now available from our partner Andbank Wealth Management.

👉Full report - andbank.es/boutiquehub/...

#PublicEquity #Fund #healthcareInvesting #BiotechSector
November 7, 2025 at 11:08 AM
ysioscapital.bsky.social
#Speaker I Terminamos el día con nuestra analista Malgorzata Rogalska en el panel “Due Diligence Decoded: Diving into VC, CVC, and Pharma Practices”

Programa completo 👉https://buff.ly/ajutCuH

#BioSpain2025 #vc
October 8, 2025 at 12:00 PM
ysioscapital.bsky.social
#Speaker I Seguimos ahora con nuestro Partner Thomas Harth en el panel “Science Meets Capital: De-risking Early Biotech to Unlock Investment”

Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda

#BioSpain2025 #vc
October 8, 2025 at 9:28 AM
ysioscapital.bsky.social
#Speaker I Hoy, nuestro Partner Guillem Laporta
participa en "The Role of Biotechnology in the Pharmaceutical Industry: Present and Future Perspectives"

Programa completo 👉https://amconferences.eventsair.com/QuickEventWebsitePortal/biospain-2025/program/Agenda

#BioSpain2025 #vc
October 8, 2025 at 9:26 AM
ysioscapital.bsky.social
#Speaker I Hoy, nuestro Managing Partner Joë Jean-Mairet
participa en "Guest Nation Switzerland: Entangling the Swiss and Spanish Biotech Ecosystems"

Programa completo 👉 amconferences.eventsair.com/QuickEventWe...

#BioSpain2025 #vc
October 7, 2025 at 10:34 AM
ysioscapital.bsky.social
#YsiosTeam I 🎉 Excited to announce Laura Argelich's promotion to #Associate at #YsiosCapital!
👏Congrats Laura, well deserved!

🔗Full profile ysioscapital.com/team/laura-a...

#vc #talent
Laura Argelich Promoted to Associate
September 30, 2025 at 1:01 PM
ysioscapital.bsky.social
#PortfolioNews I Study shows that #MAFTest® developed by our #portfolio company #Ibiomotion may save €105M in early #breast #cancer care.

🔗 Press release - buff.ly/8pAhrip
📄 Full publication here: lnkd.in/d3aUWmpp

#Oncology #HealthEconomics #BreastCancer
Journal of Medical Economics study shows significant cost savings via MAF Test® – guided adjuvant bisphosphonate therapy for early-stage breast cancer
September 18, 2025 at 1:44 PM
Reposted by Ysios Capital Partners
ara.cat
El fons d'inversió Ysios Capital ha tancat un acord de compravenda amb la multinacional suïssa CSL per un preu màxim de 2.200 milions de dòlars (uns 1.862 milions d&...
Ysios tanca un acord de venda d'una 'start-up' per un màxim de 1.862 M€
La companyia participada pel fons d'inversió està desenvolupant un tractament contra les hemorràgies
www.ara.cat
September 16, 2025 at 12:33 PM
Reposted by Ysios Capital Partners
thenewbcnpost.bsky.social
🧪 #Barcelona consolida su papel como hub emergente en ciencias de la vida con una operación internacional de gran impacto: Ysios Capital ha anunciado una alianza estratégica entre su participada VarmX y la farmacéutica australiana CSL

✍️ Elena Busquets
El papel de Barcelona en la macrooperación biomédica de VarmX y CSL, valorada en hasta 2.200 millones de dólares
Ysios Capital anuncia un acuerdo estratégico de desarrollo de un medicamento con opción de compra de su participada VarmX
www.thenewbarcelonapost.com
September 16, 2025 at 2:45 PM
ysioscapital.bsky.social
📢 #PortfolioNews | Excited to share the strategic deal of our #portfolio company #VarmX with #CSL 💊

🔹Up to $2.2B incl. $117m upfront & milestones
🔹Global Phase 3 of VMX-C001 fully funded
🌍Step closer to market for a major unmet need

👉 buff.ly/aO4iHwV

#YsiosPortfolio #vc
VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational coagulation treatment
September 16, 2025 at 10:08 AM
ysioscapital.bsky.social
#PortfolioNews I MAF Test® now adopted in top #Spanish hospitals to personalize early-stage #breast #cancer treatment. A major step for our #portfolio company #Inbiomotion !

👉 Full details here - buff.ly/aT4nwud

#BreastCancer #Oncology #PortfolioNews #MAFTest
July 18, 2025 at 11:27 AM
ysioscapital.bsky.social
#Press I 🚀¿Qué hay detrás del boom #emprendedor en #Barcelona? Fondos como @ysioscapital.bsky.social lo analizan en este artículo de @thenewbcnpost.bsky.social. No te lo pierdas!

👉 www.thenewbarcelonapost.com/el-tejido-in...

#vc #biotech
El tejido inversor como combustible para la Barcelona emprendedora
Con un ecosistema maduro, la capital catalana vive la irrupción de nuevos fondos locales y capta la atención de actores internacionales, posicionada como el principal 'hub' emprendedor del sur de Euro...
www.thenewbarcelonapost.com
July 1, 2025 at 9:05 AM
ysioscapital.bsky.social
#PODCAST I 🎙️ Inside Spain’s biggest biotech Series B ever: €119M for SpliceBio

🧬Hear how they built it from scratch, scaled fast & made history.
With CEO Miquel Vila-Perelló & @jordixiol.bsky.social (Ysios Capital).
🎧 buff.ly/Cl9x8vL

#YsiosPodcast #BiotechPillsWithJordi #vc
June 25, 2025 at 10:58 AM
ysioscapital.bsky.social
Ysios Capital led SpliceBio's Seed round in 2020, co-lead SpliceBio's €50M Series A in 2022 and has now joined this $135 million round, reaffirming its confidence in the company’s team, platform, and potential to become a key player in gene therapy.
June 11, 2025 at 9:16 AM
ysioscapital.bsky.social
Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors
June 11, 2025 at 9:16 AM
ysioscapital.bsky.social
#PortfolioNews | Proud to join the $135M Series B of our #portfolio company #SpliceBio, the largest round ever raised by a Spanish biotech 🚀

🧬 Advance SB-007 for #StargardtDisease
🔬Expand #GeneticMedicine pipeline

👉 buff.ly/jey8g9O

#VC #Biotech #Innovation #ProteinSplicing
June 11, 2025 at 9:16 AM
ysioscapital.bsky.social
📰 #PRESS I Ysios Capital abre una nueva etapa con #Telescope y mira a la transferencia tecnológica.
🔗 buff.ly/z6H7Zpt

More info 👉 buff.ly/btsAIE6
cc/ #Andbank

#vc #fund #NasdaqListed
Ysios Capital abre una nueva etapa con Telescope y mira a la transferencia tecnológica
La gestora de capital riesgo se alía con Andbank para invertir en una veintena de compañías 'biotech' que cotizen en EE.UU.
buff.ly
May 28, 2025 at 7:48 AM
ysioscapital.bsky.social
🚀 ¡Enhorabuena a nuestra analista @mrogalska.bsky.social , finalista del Premio Vanguardia de la Ciencia 2025 por su trabajo en el @crg.eu sobre el #espliceosoma humano!

📰 buff.ly/68bKHZS
👏 Orgullosos de contar con su talento en Ysios.

#MujeresEnCiencia #YsiosTeam
Cómo se editan los genes en el cuerpo humano
El genoma dice qué genes tenemos; el proteoma, qué proteínas producimos. Pero entre ambos se encuentra el espliceosoma, una maquinaria molecular esencial para editar
buff.ly
May 27, 2025 at 10:32 AM
ysioscapital.bsky.social
#Speaker | Don’t miss Karen Wagner at #SwissHLG today at 13:35 !

🎤 "Managing a portfolio of minority stakes – the view from venture capital"

#VC #Biotech #PharmaDeals #LifeSciences
May 26, 2025 at 10:11 AM
Reposted by Ysios Capital Partners
thenewbcnpost.bsky.social
🔬 En 2024, nacieron un 24% menos bebés que hace 10 años. Un cambio demográfico que responde a varios factores, como el aumento de la infertilidad. Para abordar este fenómeno, ReproNovo ha cerrado una ronda de 65 millones de dólares

✍ Ainara Valadez
ReproNovo levanta 65 millones de dólares para desarrollar terapias para la infertilidad
La ronda de financiación ha sido liderada por Jeito Capital, con la participación de AXA IM Alts, M Ventures, ALSA Ventures e Ysios Capital
www.thenewbarcelonapost.com
May 21, 2025 at 2:12 PM